-
Je něco špatně v tomto záznamu ?
Subtype-specific gout susceptibility loci and enrichment of selection pressure on ABCG2 and ALDH2 identified by subtype genome-wide meta-analyses of clinically defined gout patients
A. Nakayama, M. Nakatochi, Y. Kawamura, K. Yamamoto, H. Nakaoka, S. Shimizu, T. Higashino, T. Koyama, A. Hishida, K. Kuriki, M. Watanabe, T. Shimizu, K. Ooyama, H. Ooyama, M. Nagase, Y. Hidaka, D. Matsui, T. Tamura, T. Nishiyama, C. Shimanoe, S....
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články, metaanalýza, práce podpořená grantem
Health & Medicine (ProQuest) od 1939-01-01 do Před 6 měsíci
Family Health Database (ProQuest) od 1939-01-01 do Před 6 měsíci
Odkazy
PubMed
32238385
DOI
10.1136/annrheumdis-2019-216644
Knihovny.cz E-zdroje
- MeSH
- ABC transportér z rodiny G, člen 2 genetika MeSH
- celogenomová asociační studie * MeSH
- dna (nemoc) epidemiologie genetika MeSH
- fenotyp MeSH
- genetická predispozice k nemoci etnologie MeSH
- genetické lokusy MeSH
- genotyp MeSH
- hodnocení rizik MeSH
- incidence MeSH
- lidé MeSH
- mitochondriální aldehyddehydrogenasa genetika MeSH
- nádorové proteiny genetika MeSH
- prognóza MeSH
- referenční hodnoty MeSH
- studie případů a kontrol MeSH
- stupeň závažnosti nemoci MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- metaanalýza MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- Japonsko MeSH
OBJECTIVES: Genome-wide meta-analyses of clinically defined gout were performed to identify subtype-specific susceptibility loci. Evaluation using selection pressure analysis with these loci was also conducted to investigate genetic risks characteristic of the Japanese population over the last 2000-3000 years. METHODS: Two genome-wide association studies (GWASs) of 3053 clinically defined gout cases and 4554 controls from Japanese males were performed using the Japonica Array and Illumina Array platforms. About 7.2 million single-nucleotide polymorphisms were meta-analysed after imputation. Patients were then divided into four clinical subtypes (the renal underexcretion type, renal overload type, combined type and normal type), and meta-analyses were conducted in the same manner. Selection pressure analyses using singleton density score were also performed on each subtype. RESULTS: In addition to the eight loci we reported previously, two novel loci, PIBF1 and ACSM2B, were identified at a genome-wide significance level (p<5.0×10-8) from a GWAS meta-analysis of all gout patients, and other two novel intergenic loci, CD2-PTGFRN and SLC28A3-NTRK2, from normal type gout patients. Subtype-dependent patterns of Manhattan plots were observed with subtype GWASs of gout patients, indicating that these subtype-specific loci suggest differences in pathophysiology along patients' gout subtypes. Selection pressure analysis revealed significant enrichment of selection pressure on ABCG2 in addition to ALDH2 loci for all subtypes except for normal type gout. CONCLUSIONS: Our findings on subtype GWAS meta-analyses and selection pressure analysis of gout will assist elucidation of the subtype-dependent molecular targets and evolutionary involvement among genotype, phenotype and subtype-specific tailor-made medicine/prevention of gout and hyperuricaemia.
Akasaka Central Clinic Tokyo Japan
Cancer Prevention Center Chiba Cancer Center Research Institute Chiba Japan
Department of Biochemisty University of Otago Dunedin New Zealand
Department of Medical Biochemistry Kurume University School of Medicine Kurume Japan
Department of Pharmacy The University of Tokyo Hospital Tokyo Japan
Department of Preventive Medicine Nagoya University Graduate School of Medicine Nagoya Japan
Department of Public Health Nagoya City University Graduate School Medical Science Nagoya Japan
Division of Department of Nursing Nagoya University Graduate School of Medicine Nagoya Japan
Faculty of Medical Science Teikyo University of Science Tokyo Japan
Group of Privacy Controls Tohoku Medical Megabank Organization Sendai Japan
Laboratory for Mathematics National Defense Medical College Tokorozawa Japan
Midorigaoka Hospital Takatsuki Japan Kyoto Industrial Health Association Kyoto Japan
RIKEN Center for Integrative Medical Sciences Yokohama Japan
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20025035
- 003
- CZ-PrNML
- 005
- 20201222153644.0
- 007
- ta
- 008
- 201125s2020 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1136/annrheumdis-2019-216644 $2 doi
- 035 __
- $a (PubMed)32238385
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Nakayama, Akiyoshi $u Department of Integrative Physiology and Bio-Nano Medicine, National Defense Medical College, Tokorozawa, Japan. Medical Squadron, Air Base Group, Western Aircraft Control and Warning Wing, Japan Air Self-Defense Force, Kasuga, Japan.
- 245 10
- $a Subtype-specific gout susceptibility loci and enrichment of selection pressure on ABCG2 and ALDH2 identified by subtype genome-wide meta-analyses of clinically defined gout patients / $c A. Nakayama, M. Nakatochi, Y. Kawamura, K. Yamamoto, H. Nakaoka, S. Shimizu, T. Higashino, T. Koyama, A. Hishida, K. Kuriki, M. Watanabe, T. Shimizu, K. Ooyama, H. Ooyama, M. Nagase, Y. Hidaka, D. Matsui, T. Tamura, T. Nishiyama, C. Shimanoe, S. Katsuura-Kamano, N. Takashima, Y. Shirai, M. Kawaguchi, M. Takao, R. Sugiyama, Y. Takada, T. Nakamura, H. Nakashima, M. Tsunoda, I. Danjoh, A. Hozawa, K. Hosomichi, Y. Toyoda, Y. Kubota, T. Takada, H. Suzuki, B. Stiburkova, TJ. Major, TR. Merriman, N. Kuriyama, H. Mikami, T. Takezaki, K. Matsuo, S. Suzuki, T. Hosoya, Y. Kamatani, M. Kubo, K. Ichida, K. Wakai, I. Inoue, Y. Okada, N. Shinomiya, H. Matsuo, Japan Gout Genomics Consortium (Japan Gout),
- 520 9_
- $a OBJECTIVES: Genome-wide meta-analyses of clinically defined gout were performed to identify subtype-specific susceptibility loci. Evaluation using selection pressure analysis with these loci was also conducted to investigate genetic risks characteristic of the Japanese population over the last 2000-3000 years. METHODS: Two genome-wide association studies (GWASs) of 3053 clinically defined gout cases and 4554 controls from Japanese males were performed using the Japonica Array and Illumina Array platforms. About 7.2 million single-nucleotide polymorphisms were meta-analysed after imputation. Patients were then divided into four clinical subtypes (the renal underexcretion type, renal overload type, combined type and normal type), and meta-analyses were conducted in the same manner. Selection pressure analyses using singleton density score were also performed on each subtype. RESULTS: In addition to the eight loci we reported previously, two novel loci, PIBF1 and ACSM2B, were identified at a genome-wide significance level (p<5.0×10-8) from a GWAS meta-analysis of all gout patients, and other two novel intergenic loci, CD2-PTGFRN and SLC28A3-NTRK2, from normal type gout patients. Subtype-dependent patterns of Manhattan plots were observed with subtype GWASs of gout patients, indicating that these subtype-specific loci suggest differences in pathophysiology along patients' gout subtypes. Selection pressure analysis revealed significant enrichment of selection pressure on ABCG2 in addition to ALDH2 loci for all subtypes except for normal type gout. CONCLUSIONS: Our findings on subtype GWAS meta-analyses and selection pressure analysis of gout will assist elucidation of the subtype-dependent molecular targets and evolutionary involvement among genotype, phenotype and subtype-specific tailor-made medicine/prevention of gout and hyperuricaemia.
- 650 _2
- $a ABC transportér z rodiny G, člen 2 $x genetika $7 D000070997
- 650 _2
- $a mitochondriální aldehyddehydrogenasa $x genetika $7 D000071396
- 650 _2
- $a studie případů a kontrol $7 D016022
- 650 _2
- $a genetické lokusy $7 D056426
- 650 _2
- $a genetická predispozice k nemoci $x etnologie $7 D020022
- 650 12
- $a celogenomová asociační studie $7 D055106
- 650 _2
- $a genotyp $7 D005838
- 650 _2
- $a dna (nemoc) $x epidemiologie $x genetika $7 D006073
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a incidence $7 D015994
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a nádorové proteiny $x genetika $7 D009363
- 650 _2
- $a fenotyp $7 D010641
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a referenční hodnoty $7 D012016
- 650 _2
- $a hodnocení rizik $7 D018570
- 650 _2
- $a stupeň závažnosti nemoci $7 D012720
- 651 _2
- $a Japonsko $7 D007564
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a metaanalýza $7 D017418
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Nakatochi, Masahiro $u Division of Department of Nursing, Nagoya University Graduate School of Medicine, Nagoya, Japan.
- 700 1_
- $a Kawamura, Yusuke $u Department of Integrative Physiology and Bio-Nano Medicine, National Defense Medical College, Tokorozawa, Japan. Department of General Medicine, National Defense Medical College, Tokorozawa, Japan.
- 700 1_
- $a Yamamoto, Ken $u Department of Medical Biochemistry, Kurume University School of Medicine, Kurume, Japan.
- 700 1_
- $a Nakaoka, Hirofumi $u Division of Human Genetics, Department of Integrated Genetics, National Institute of Genetics, Mishima, Japan.
- 700 1_
- $a Shimizu, Seiko $u Department of Integrative Physiology and Bio-Nano Medicine, National Defense Medical College, Tokorozawa, Japan.
- 700 1_
- $a Higashino, Toshihide $u Department of Integrative Physiology and Bio-Nano Medicine, National Defense Medical College, Tokorozawa, Japan. Graduate School of Information Science and Technology, Hokkaido University, Sapporo, Japan.
- 700 1_
- $a Koyama, Teruhide $u Department of Epidemiology for Community Health and Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.
- 700 1_
- $a Hishida, Asahi $u Department of Preventive Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.
- 700 1_
- $a Kuriki, Kiyonori $u Laboratory of Public Health, School of Food and Nutritional Sciences, University of Shizuoka, Shizuoka, Japan.
- 700 1_
- $a Watanabe, Miki $u Department of Public Health, Nagoya City University Graduate School Medical Science, Nagoya, Japan.
- 700 1_
- $a Shimizu, Toru $u Midorigaoka Hospital, Takatsuki, Japan. Kyoto Industrial Health Association, Kyoto, Japan.
- 700 1_
- $a Ooyama, Keiko $u Ryougoku East Gate Clinic, Tokyo, Japan.
- 700 1_
- $a Ooyama, Hiroshi $u Ryougoku East Gate Clinic, Tokyo, Japan.
- 700 1_
- $a Nagase, Mitsuo $u Nagase Clinic, Tokyo, Japan.
- 700 1_
- $a Hidaka, Yuji $u Akasaka Central Clinic, Tokyo, Japan.
- 700 1_
- $a Matsui, Daisuke $u Department of Epidemiology for Community Health and Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.
- 700 1_
- $a Tamura, Takashi $u Department of Preventive Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.
- 700 1_
- $a Nishiyama, Takeshi $u Department of Public Health, Nagoya City University Graduate School Medical Science, Nagoya, Japan.
- 700 1_
- $a Shimanoe, Chisato $u Department of Preventive Medicine, Faculty of Medicine, Saga University, Saga, Japan. Clinical Research Center, Saga University Hospital, Saga, Japan.
- 700 1_
- $a Katsuura-Kamano, Sakurako $u Department of Preventive Medicine, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan.
- 700 1_
- $a Takashima, Naoyuki $u Department of Health Science, Shiga University of Medical Science, Otsu, Japan. Department of Public Health, Faculty of Medicine, Kindai University, Osaka-Sayama, Japan.
- 700 1_
- $a Shirai, Yuya $u Department of Statistical Genetics, Osaka University Graduate School of Medicine, Suita, Japan. Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Suita, Japan.
- 700 1_
- $a Kawaguchi, Makoto $u Department of Integrative Physiology and Bio-Nano Medicine, National Defense Medical College, Tokorozawa, Japan. Department of Urology, National Defense Medical College, Tokorozawa, Japan.
- 700 1_
- $a Takao, Mikiya $u Department of Integrative Physiology and Bio-Nano Medicine, National Defense Medical College, Tokorozawa, Japan. Department of Surgery, National Defense Medical College, Tokorozawa, Japan.
- 700 1_
- $a Sugiyama, Ryo $u Department of Integrative Physiology and Bio-Nano Medicine, National Defense Medical College, Tokorozawa, Japan.
- 700 1_
- $a Takada, Yuzo $u Faculty of Medical Science, Teikyo University of Science, Tokyo, Japan.
- 700 1_
- $a Nakamura, Takahiro $u Laboratory for Mathematics, National Defense Medical College, Tokorozawa, Japan.
- 700 1_
- $a Nakashima, Hiroshi $u Department of Preventive Medicine and Public Health, National Defense Medical College, Tokorozawa, Japan.
- 700 1_
- $a Tsunoda, Masashi $u Department of Preventive Medicine and Public Health, National Defense Medical College, Tokorozawa, Japan.
- 700 1_
- $a Danjoh, Inaho $u Group of Privacy Controls, Tohoku Medical Megabank Organization, Sendai, Japan.
- 700 1_
- $a Hozawa, Atsushi $u Department of Preventive Medicine and Epidemiology, Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.
- 700 1_
- $a Hosomichi, Kazuyoshi $u Department of Bioinformatics and Genomics, Graduate School of Advanced Preventive Medical Sciences, Kanazawa University, Kanazawa, Japan.
- 700 1_
- $a Toyoda, Yu $u Department of Pharmacy, The University of Tokyo Hospital, Tokyo, Japan.
- 700 1_
- $a Kubota, Yu $u Department of Pharmacy, The University of Tokyo Hospital, Tokyo, Japan.
- 700 1_
- $a Takada, Tappei $u Department of Pharmacy, The University of Tokyo Hospital, Tokyo, Japan.
- 700 1_
- $a Suzuki, Hiroshi $u Department of Pharmacy, The University of Tokyo Hospital, Tokyo, Japan.
- 700 1_
- $a Stiburkova, Blanka $u Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic. Institute of Rheumatology, Prague, Czech Republic.
- 700 1_
- $a Major, Tanya J $u Department of Biochemisty, University of Otago, Dunedin, New Zealand.
- 700 1_
- $a Merriman, Tony R $u Department of Biochemisty, University of Otago, Dunedin, New Zealand.
- 700 1_
- $a Kuriyama, Nagato $u Department of Epidemiology for Community Health and Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.
- 700 1_
- $a Mikami, Haruo $u Cancer Prevention Center, Chiba Cancer Center Research Institute, Chiba, Japan.
- 700 1_
- $a Takezaki, Toshiro $u Department of International Island and Community Medicine, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
- 700 1_
- $a Matsuo, Keitaro $u Division of Cancer Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan. Department of Epidemiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
- 700 1_
- $a Suzuki, Sadao $u Department of Public Health, Nagoya City University Graduate School Medical Science, Nagoya, Japan.
- 700 1_
- $a Hosoya, Tatsuo $u Division of Kidney and Hypertension, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan. Department of Pathophysiology and Therapy in Chronic Kidney Disease, Jikei University School of Medicine, Tokyo, Japan.
- 700 1_
- $a Kamatani, Yoichiro $u Laboratory for Statistical Analysis, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan. Center for Genomic Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.
- 700 1_
- $a Kubo, Michiaki $u RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
- 700 1_
- $a Ichida, Kimiyoshi $u Division of Kidney and Hypertension, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan. Department of Pathophysiology, Tokyo University of Pharmacy and Life Science, Hachioji, Japan.
- 700 1_
- $a Wakai, Kenji $u Department of Preventive Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.
- 700 1_
- $a Inoue, Ituro $u Division of Human Genetics, Department of Integrated Genetics, National Institute of Genetics, Mishima, Japan.
- 700 1_
- $a Okada, Yukinori $u Department of Statistical Genetics, Osaka University Graduate School of Medicine, Suita, Japan. Laboratory of Statistical Immunology, Immunology Frontier Research Center (WPI-IFReC), Osaka University, Suita, Japan.
- 700 1_
- $a Shinomiya, Nariyoshi $u Department of Integrative Physiology and Bio-Nano Medicine, National Defense Medical College, Tokorozawa, Japan.
- 700 1_
- $a Matsuo, Hirotaka $u Department of Integrative Physiology and Bio-Nano Medicine, National Defense Medical College, Tokorozawa, Japan hmatsuo@ndmc.ac.jp.
- 710 2_
- $a Japan Gout Genomics Consortium (Japan Gout)
- 773 0_
- $w MED00000444 $t Annals of the rheumatic diseases $x 1468-2060 $g Roč. 79, č. 5 (2020), s. 657-665
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32238385 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20201222153640 $b ABA008
- 999 __
- $a ok $b bmc $g 1599180 $s 1115721
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 79 $c 5 $d 657-665 $e 20200401 $i 1468-2060 $m Annals of the rheumatic diseases $n Ann Rheum Dis $x MED00000444
- LZP __
- $a Pubmed-20201125